Akebia Therapeutics Inc.
AKBA
|
|
| |
|
| Trading Volume | 40,578 |
|
|
2.22 - 0.80 |
| Market Cap Full | $ 286.4M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 0.3% | 51.6% | -3% | -68.2% |
| Q2 | - | -40.5% | 63.4% | -50.8% |
| Q3 | - | 10.1% | 24.6% | -10.5% |
| Q4 | - | -6.9% | 7.8% | 82.6% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.3 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 35.5 | -6 | 19 | -27.7 | -19.1 | -11.8 | 42.3 | 10.1 | - | - | - | - |
| 2023 | |||||||||||
| 9.2 | 33.8 | -33.6 | 62.3 | 14.4 | -12 | 82.5 | -16.8 | -18 | -22.8 | 20.5 | 17 |
| 2022 | |||||||||||
| -13.7 | 10.8 | -66.8 | -41.8 | -11.5 | -4.6 | 10.8 | -6.9 | -13.2 | -19.3 | 6.3 | 112.9 |
| 2021 | |||||||||||
| 15.7 | 6.8 | -2.2 | -5.8 | 12.3 | 5.8 | -34.8 | 19 | -2 | -0.4 | -5.6 | -16.6 |
| 2020 | |||||||||||
| 11.1 | 22.9 | -14.5 | 6.9 | 43.7 | 16.7 | -17.8 | -7.1 | -75.8 | -11.6 | 49.1 | -15.4 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.1 | -0.4 | -0.5 | -0.5 |
| Q2 | -0.1 | 0.2 | -0.5 | -1.3 |
| Q3 | -0.1 | -0.3 | -0.3 | -0.4 |
| Q4 | 0 | -0 | -0.4 | -0.6 |
| A | -0.28 | -0.5 | -1.7 | -2.8 |